On March 14, So-Young, a medical aesthetics O2O platform, officially announced the completion of its Series C financing. Its founder, Jin Xing, disclosed that the funding round amounted to $50 million, with investors including UYIPIN and Tencent’s “Double Hundred Plan.”
Joining Tencent’s “Double Hundred” Initiative has further strengthened So-Young’s consumer-side user acquisition, building on its existing strategic partnerships with numerous medical aesthetic institutions.
Enter the market through minimally invasive cosmetic procedures, following the “So-Young Model”
Compared with other categories of plastic surgery, minimally invasive procedures are more standardized, have higher consumption frequency, are safer, enjoy greater consumer acceptance, and are better suited for digitalization. Therefore, So-Young chose to start fromMinimally Invasive Cosmetic Proceduresto enter the medical aesthetics market, foregoing surgical plastic procedures with higher average transaction values and profit margins.
Therefore, in selecting institutional partners, So-Young opted to collaborate primarily with small and medium-sized private medical aesthetics clinics, rather than large private hospitals affiliated with the “Putian network,” which mainly focus on developing high-ticket surgical procedures. Public hospitals were not chosen for two main reasons: first, their pricing is strictly regulated, rendering non-surgical aesthetic treatments uncompetitive in terms of price; second, most physicians in public hospitals prefer performing surgical interventions, as they consider these procedures more technically demanding and better aligned with their professional identity as “plastic surgeons.”
Compared with public hospitals and large private hospitals, small and medium-sized clinics are more reliant on So-Young. This is mainly because they do not have sufficient funds for advertising. In terms of medical service quality, So-Young believes that doctors who can open their own clinics usually possess rich technical skills and experience. Their operations are entirely market-oriented; they primarily provide services that consumers prefer. For plastic surgeons with over a decade of formal training and experience, performing minimally invasive cosmetic procedures presents little difficulty.
Starting with minimally invasive cosmetic procedures, So-Young has carved out its own development model, namely:Social e-commerce model, with its core lying in the socialization of decision-making and the e-commercialization of medical services。
By leveraging the extensive transaction data on medical services available on the SoYoung platform, consumers can determine which hospitals and physicians are more popular and identify the specific areas of expertise for different doctors.In consumer healthcare sectors such as medical aesthetics, e-commerce integration can enhance price transparency and foster fairer competition.
It is reported that SoYoung currently processes nearly 60,000 orders per month for minimally invasive cosmetic procedures.
Private clinics are core partners, leveraging the “Cloud Clinic” sharing economy.
For So-Young, the platform’s primary partners are private clinics operated by plastic surgeons, to which it allocates substantial resources. These privately owned clinics have complete operational teams and independent pricing authority, while maintaining consistent standards in medical services. The significant resources So-Young invests in these private clinics yield substantial returns: users from the So-Young platform often account for 30% to 50% of new monthly patients at key partner clinics. This high proportion of clients, in turn, encourages these clinics to place greater emphasis on service quality and treatment outcomes for customers on the So-Young platform, creating a virtuous cycle that ultimately benefits consumers.
In its collaboration with physicians, So-Young not only promotes them online but also assists in resolving offline issues related to practice qualifications and clinical facilities, thereby helping physicians build comprehensive service and treatment capabilities. This led to the launch of So-Young’s “Cloud Clinic.”
SoYoung’s “Cloud Clinic” leverages a sharing economy model to integrate the idle time and equipment of small and medium-sized clinics under standardized, unified management. This infrastructure is made accessible to the numerous public-hospital physicians on the SoYoung platform, thereby maximizing resource utilization while resolving venue constraints associated with physicians’ multi-site practice. As the entire service ecosystem operates under SoYoung’s oversight, consumers can have full confidence in physician credentials and the authenticity of medications, allowing physicians to dedicate their time to patient care with maximum efficiency.
Currently, So-Young has three cloud clinics under construction and plans to partner in establishing 200 cloud clinics across China within the next three years, serving thousands of plastic surgeons.
Following the Series C funding round, founder Jin Xing positioned So-Young as a “connector” linking consumers, medical aesthetic institutions, physicians, insurance and financial institutions, as well as pharmaceutical and equipment manufacturers. Taking pharmaceutical and equipment manufacturers as an example, branded companies in the medical aesthetics industry still rely on the traditional pharmaceutical representative model, with channel costs reaching as high as 60%. Through So-Young, consumers can be directly connected with branded equipment manufacturers, enabling them to gain direct insight into the performance specifications, advantages, and disadvantages of various hyaluronic acid fillers, botulinum toxin products, and laser devices. Meanwhile, So-Young’s nationwide business development (BD) team can facilitate the direct entry of pharmaceuticals and equipment into hospitals, significantly reducing intermediary channels, improving efficiency, and lowering costs.